- Home
- ADX vs CRNX Comparison
ADX vs CRNX Comparison
Compare ADX & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADX
- CRNX
- Stock Information
- Founded
- ADX 1840
- CRNX 2008
- Country
- ADX United States
- CRNX United States
- Employees
- ADX N/A
- CRNX N/A
- Industry
- ADX Investment Managers
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- ADX Finance
- CRNX Health Care
- Exchange
- ADX Nasdaq
- CRNX Nasdaq
- Market Cap
- ADX 2.7B
- CRNX 2.8B
- IPO Year
- ADX N/A
- CRNX 2018
- Fundamental
- Price
- ADX $23.18
- CRNX $42.06
- Analyst Decision
- ADX
- CRNX Buy
- Analyst Count
- ADX 0
- CRNX 12
- Target Price
- ADX N/A
- CRNX $74.45
- AVG Volume (30 Days)
- ADX 182.4K
- CRNX 1.5M
- Earning Date
- ADX 01-01-0001
- CRNX 11-06-2025
- Dividend Yield
- ADX 6.68%
- CRNX N/A
- EPS Growth
- ADX N/A
- CRNX N/A
- EPS
- ADX N/A
- CRNX N/A
- Revenue
- ADX N/A
- CRNX $1,392,000.00
- Revenue This Year
- ADX N/A
- CRNX $420.79
- Revenue Next Year
- ADX N/A
- CRNX $993.85
- P/E Ratio
- ADX N/A
- CRNX N/A
- Revenue Growth
- ADX N/A
- CRNX 0.51
- 52 Week Low
- ADX $14.94
- CRNX $24.10
- 52 Week High
- ADX $19.57
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- ADX 69.09
- CRNX 53.31
- Support Level
- ADX $22.61
- CRNX $39.88
- Resistance Level
- ADX $22.94
- CRNX $44.54
- Average True Range (ATR)
- ADX 0.27
- CRNX 1.93
- MACD
- ADX 0.04
- CRNX -0.47
- Stochastic Oscillator
- ADX 90.22
- CRNX 35.33
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.